VRDN icon

Viridian Therapeutics
VRDN

Overview Fund Activity

178 hedge funds and large institutions have $1.75B invested in Viridian Therapeutics in 2024 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 79 increasing their positions, 42 reducing their positions, and 24 closing their positions.

Holders
178
Holders Change
+13
Holders Change %
+7.88%
% of All Funds
2.37%
Holding in Top 10
12
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+20%
% of All Funds
0.16%
New
42
Increased
79
Reduced
42
Closed
24
Calls
$9.76M
Puts
$20.4M
Net Calls
-$10.6M
Net Calls Change
-$11.6M

Top Buyers

1
Loomis, Sayles & Company
1
Loomis, Sayles & Company
Massachusetts
$26.8M
2
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$25.4M
3
State Street
3
State Street
Massachusetts
$67.5M
4
BlackRock
4
BlackRock
New York
$110M
5
KCM
5
Kynam Capital Management
New Jersey
$63.8M

Top Sellers

1
EC
1
EcoR1 Capital
California
$0
2
PA
2
Perceptive Advisors
New York
$28.5M
3
PBA
3
Paradigm Biocapital Advisors
New York
$34.9M
4
Marshall Wace
4
Marshall Wace
United Kingdom
$0
5
VC
5
Vivo Capital
California
$18.8M
Name Holding Trade Value Shares
Change 		Shares
Change %
VAMG
201
Voisard Asset Management Group
Michigan
– -$2.28K -100 Closed
National Bank of Canada
202
National Bank of Canada
Quebec, Canada
– -$2.28K -100 Closed
5 6 7 8
9